{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:29:20Z","timestamp":1792290560016,"version":"4.4.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.transci.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T13:28:32Z","timestamp":1518701312000},"page":"225-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic plasma exchange for hyperviscosity syndrome secondary to high rheumatoid factor"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3571-4102","authenticated-orcid":false,"given":"Parvez M.","family":"Lokhandwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shabihkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan M.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2018.02.004_bib0005","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0002-9343(87)90172-0","article-title":"Pulmonary hypertension secondary to serum hyperviscosity in a patient with rheumatoid arthritis","volume":"82","author":"Eaton","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.transci.2018.02.004_bib0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.1965.03080190030008","article-title":"Serum hyperviscosity syndrome","volume":"192","author":"Fahey","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2018.02.004_bib0015","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.1780200713","article-title":"Polyclonal hyperviscosity syndrome","volume":"20","author":"Hadler","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2018.02.004_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jca.10018","article-title":"Serum hyperviscosity syndrome responding to therapeutic plasmapheresis in a patient with primary Sjogren's syndrome","volume":"17","author":"Simon","year":"2002","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2018.02.004_bib0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0049-0172(98)80018-8","article-title":"Rheumatoid hyperviscosity: analysis of a patient with intermediate complexes that block other autoantibodies and a review of the literature","volume":"27","author":"Scofield","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.transci.2018.02.004_bib0030","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1445-5994.1989.tb00341.x","article-title":"Hyperviscosity syndrome secondary to rheumatoid arthritis","volume":"19","author":"Bach","year":"1989","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.transci.2018.02.004_bib0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0161-6420(86)33782-5","article-title":"Hyperviscosity retinopathy secondary to polyclonal gammopathy in a patient with rheumatoid arthritis","volume":"93","author":"Sarnat","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.transci.2018.02.004_bib0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0002-9394(02)01504-0","article-title":"Rheumatoid hyperviscosity syndrome: reversibility of microvascular abnormalities after treatment","volume":"134","author":"Rezai","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.transci.2018.02.004_bib0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/1756-185X.12751","article-title":"Hyperviscosity in primary Sjogren's syndrome: clinical implications","volume":"20","author":"Hernandez-Molina","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.transci.2018.02.004_bib0050","first-page":"149","article-title":"Guidelines on the use of therapeutic Apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the Seventh Special Issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2018.02.004_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/art.1780180201","article-title":"The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors","volume":"18","author":"Pope","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transci.2018.02.004_bib0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9343(70)80043-2","article-title":"Rheumatoid hyperviscosity syndrome","volume":"49","author":"Jasin","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.transci.2018.02.004_bib0065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","article-title":"Cryoglobulinemia\u2013a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305021830034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305021830034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T10:44:01Z","timestamp":1529145841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305021830034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S147305021830034X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2018.02.004","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic plasma exchange for hyperviscosity syndrome secondary to high rheumatoid factor","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}